Epigenetics and Nanomedicine

CINN’s Nanomedicine research group was established in 2015 as a result of the center’s increased activity in the biomedical field.

The ongoing research lines are focused on six main areas:

  • Application of next generation technologies in the search for epigenetic biomarkers related to aging and human tumorigenesis which are useful in clinical practice.
  • Identification of epigenetic changes in response to nanomaterials, and especially to graphene and graphenic nanomaterials.
  • Development of nanocarriers for epigenetic antitumor drug delivery.
  •  Analysis in situ of the subcellular architecture through nanotomography and image processing and application to the study of neurodegenerative diseases.
  • Novel inorganic antimicrobial products.
  • Tissue engineering: Solutions to avoid peri-implantitis, ceramic materials for long-lasting implants, bone scaffolds, etc.

Our researchers also lead 3 of the research groups of the Health Research Institute of Asturias (ISPA):

nanomedicine